FYN, SARS-CoV-2, and IFITM3 in the neurobiology of Alzheimer's disease
Open Access
- 18 August 2021
- journal article
- research article
- Published by Elsevier BV in Brain Disorders
- Vol. 3, 100022
- https://doi.org/10.1016/j.dscb.2021.100022
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer's disease transgenic miceAging Cell, 2013
- The Small Molecules AZD0530 and Dasatinib Inhibit Dengue Virus RNA Replication via Fyn KinaseJournal of Virology, 2013
- Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s DiseaseCell, 2013
- Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer diseasePrion, 2013
- Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer's diseaseNeurobiology of Aging, 2012
- The N-Terminal Region of IFITM3 Modulates Its Antiviral Activity by Regulating IFITM3 Cellular LocalizationJournal of Virology, 2012
- The Role of Src Kinase in Macrophage-Mediated Inflammatory ResponsesMediators of Inflammation, 2012
- Genetic Control of Human Brain Transcript Expression in Alzheimer DiseaseAmerican Journal of Human Genetics, 2009
- Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in ManPLoS Pathogens, 2009
- WGCNA: an R package for weighted correlation network analysisBMC Bioinformatics, 2008